Exacerbation of whipple disease by immunosuppressants

Journal of Clinical Gastroenterology

Volumn 42, Issue 6, 2008, Pages 760-761

  Lamparter, Steffen ^a   Dittrich, Christoph ^a   Koehler, Heinz H ^b  

^a Diakonie Krankenhaus   (Germany)

^b Department of Pathology and Cytology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; COTRIMOXAZOLE; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLE DERIVATIVE;

ABDOMINAL PAIN; AGED; ARTHROPATHY; CASE REPORT; CHRONIC DIARRHEA; CLINICAL ASSESSMENT; CLINICAL FEATURE; DELAYED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; GENERAL CONDITION DETERIORATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE LIPODYSTROPHY; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TROPHERYMA WHIPPELII; ADULT ONSET STILL DISEASE; DIAGNOSTIC ERROR; PATHOPHYSIOLOGY;

AGED; DIAGNOSTIC ERRORS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MALE; STILL'S DISEASE, ADULT-ONSET; WHIPPLE DISEASE;

EID: 54749136674     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3180318aea     Document Type: Letter

References (6)

1. Marth T, Raoult D. Whipple's disease. Lancet. 2003;361:239-246.
2. Moos V, Kunkel D, Marth T, et al. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease. J Immunol. 2006;177: 2015-2022.
3. Deriban G, Marth T. Current concepts of immunopathogenesis, diagnosis and therapy in Whipple's disease. Curr Med Chem. 2006; 13:2921-2926.
4. Mahnel R, Kalt A, Ring S, et al. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol. 2005;100:1167-1173.
5. Yao HW, Li J, Chen JQ, et al. A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells. Inflammation. 2004;28:97-103.
6. Kneitz C, Suerbaum S, Beer M, et al. Exacerbation of Whipple's disease associated with infliximab treatment. Scand J Rheumatol. 2005;34:148-151.